|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Interferon beta-1b (CAS 145155-23-3) Market Research Report 2025 December 2025 Insulin Porcine (CAS 9008-11-1) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Interferons Market Product Type (Interferon Alpha, Interferon Beta, Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma), Regional Forecasts 2021-2027 ... is generated by selling of several types of interferons, such as alpha, beta, and ... target affinity and specificity of interferons and increasing prevalence of diseases ... of specialists. As a result, demand for interferons will be much greater in the North ... Investigation Report on China's Recombinant Human Interferon ?2b Market, 2018-2022 ... Co., Ltd.'s Recombinant Human Interferon ?2b was approved to be sold in ... Recombinant Human Interferon ?2b in China Prices of Recombinant Human Interferon ?2b in China ... influencing development of Recombinant Human Interferon ?2b in China Prospect of China's ... Global Interferon Market & Pipeline Analysis 2015 ... 2015” Report Highlights: Introduction & Classification of Interferons Interferon Clinical Pipeline Country, Indication & Phase ... Interferon Clinical Pipeline: 79 Drugs Majority Interferon Drugs in Preclinical Phase ... Stimulator Of Interferon Genes Protein (Endoplasmic Reticulum Interferon Stimulator or Mediator Of IRF3 Activation or Transmembrane Protein 173 or STING or TMEM173) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players ... in depth analysis on Stimulator Of Interferon Genes Protein (Endoplasmic Reticulum Interferon Stimulator or Mediator Of IRF3 ... projects by understanding Stimulator Of Interferon Genes Protein (Endoplasmic Reticulum Interferon Stimulator or Mediator Of IRF3 ... Interleukin 6 (B Cell Stimulatory Factor 2 or BSF2 or CTL Differentiation Factor or CDF or Hybridoma Growth Factor or Interferon Beta 2 or IFNB2 or IL6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players ... Factor or CDF or Hybridoma Growth Factor or Interferon Beta 2 or IFNB2 or IL6) targeted ... Factor or CDF or Hybridoma Growth Factor or Interferon Beta 2 or IFNB2 or IL6) targeted ... or CDF or Hybridoma Growth Factor or Interferon Beta 2 or IFNB2 or IL6) targeted ... Amarillo Biosciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... influenza, using natural human interferon alpha that is administered in a proprietary ... oral delivery of interferon. Its product is a natural human interferon alpha administered ... technology relating to the production of interferon alpha-containing lozenges by ... Hemispherx Biopharma, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... , oral liquid formulation of Natural Alpha Interferon. It is an experimental immunotherapeutic believed to work by stimulating ... of Hemispherx' primary products, Alferon N InjectionR (interferon Alfa-n3). Hemispherx Biopharma and Max ... Anhui Anke Biotechnology (Group) Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... interferon a 2b for injection, recombinant human interferon a 2b cream, recombinant human interferon a 2b eyedrop, recombinant human interferon ... affinity gel to a-interferon under the Anterferon trade ... antibody affinity gel to a-interferon under the 4C1- ... The 2026-2031 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis ... the world outlook for beta interferon therapeutics for multiple sclerosis ... report we define the sales of beta interferon therapeutics for multiple sclerosis as including ... demand, or the P.I.E., for beta interferon therapeutics for multiple sclerosis. It also ... The 2026-2031 World Outlook for Blood and Tissue Interferon Growth Factors ... outlook for blood and tissue interferon growth factors across more than ... the sales of blood and tissue interferon growth factors as including all commonly ... , or the P.I.E., for blood and tissue interferon growth factors. It also shows how ... Momenta Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... United States. These include Rebif (interferon-beta-1a), which is co-promoted by EMD ... Serono in the European Union; Avonex (interferon beta-1a) and Tysabri (natalizumab) ... Biogen Idec Inc., and Betaseron (interferon-beta-1b), which is marketed by Bayer ... Myrexis, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... MPI-485520 is an oral anti-interferon. MPI-485520 potently and selectively ... model. In cellular models of type I interferon production, MPI-485520 potently inhibits ... induction of type I interferons (IFNa/b) following stimulation of various ... PROLOR Biotech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... biopharmaceuticals: Human Growth Hormone (hGH); Interferon â; Factor VIIa, Factor IX; Erythropoietin (EPO ... surgery where blood loss is expected. Interferon â: Beta interferon is a drug used to reduce the ... Vital Group Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... micro-bioencapsulated technology are: Proteins: Interferon-¦Á, Hyaluronic acid, Erythropoietin (EPO), ... and Spray-On Bandage. Opin: interferon tablet for vaginal delivery ... Products under development include: nasal interferon spray and sublingual EPO. ... Achillion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... for the treatment of hepatitis C, the interferon-alpha based products from Roche ... compounds may compete with the interferon and ribavirin based drugs in development ... Anadys Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... trial of ANA598 in combination with pegylated interferon-alpha and ribavirin. ANA773: The ... is an oral, small-molecule inducer of endogenous interferons that acts through the Toll ... Helix Biopharma Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... focused on its L-DOS47 and Topical Interferon Alpha-2b new drug candidates. DOS47 ... . Alpha-2b The company, for Topical Interferon Alpha-2b, has been working on two ... InterMune Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... with the development and commercialization of interferon gamma-1b in Europe and the rest ... oral antiviral molecules in the absence of interferon. The initial study would evaluate ... |